On ECHEMI
Home > Drugs > Allopurinol Registered Holders
Allopurinol structure

Allopurinol structure

Allopurinol

Allopurinol (Zyloprim) is a xanthine oxidase inhibitor with an IC50 of 7.82±0.12 μM.Target: XAOAllopurinol (Zyloprim, and generics) is a drug used primarily to treat hyperuricemia (excess uric acid in blood plasma) and its complications, including chronic gout. It is a xanthine oxidase inhibitor which is administered orally. A common misconception is that allopurinol is metabolized by its target, xanthine oxidase, but this action is principally carried out by Aldehyde oxidase. The active

Find 67 Related Holders

EGIS Pharmaceuticals PLC
European Union European Union

API Registration Country

API Active
SIGNA S.A.
European Union European Union

API Registration Country

API Active
Union Quimico Farmaceutica S.A.
European Union European Union

API Registration Country

API Active
Harman Finochem Ltd
United States United States

API Registration Country

API Active
SCI Pharmtech Inc.
European Union European Union

API Registration Country

API Active
SCI PHARMTECH INC
United States United States

API Registration Country

API Active
Unichem Laboratories Ltd
United States United States

API Registration Country

API Active
SMS LIFESCIENCES INDIA LTD
United States United States

API Registration Country

API Active
ANHUI POLY PHARM CO LTD
United States United States

API Registration Country

API Active
HENAN DONGTAI PHARM CO LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Allopurinol
View 231 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.